Bernd Ibach

2.1k total citations
46 papers, 861 citations indexed

About

Bernd Ibach is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Bernd Ibach has authored 46 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 17 papers in Physiology and 13 papers in Pharmacology. Recurrent topics in Bernd Ibach's work include Dementia and Cognitive Impairment Research (16 papers), Alzheimer's disease research and treatments (15 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Bernd Ibach is often cited by papers focused on Dementia and Cognitive Impairment Research (16 papers), Alzheimer's disease research and treatments (15 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Bernd Ibach collaborates with scholars based in Germany, United Kingdom and Switzerland. Bernd Ibach's co-authors include Ekkehard Haen, Göran Hajak, Jörg Marienhagen, Tobias Schmidt‐Wilcke, Matthias W. Riepe, Katrin Döhnel, Jörg Meinhardt, Hans H. Klünemann, Monika Sommer and Markus J. Riemenschneider and has published in prestigious journals such as NeuroImage, American Journal of Psychiatry and Annals of Neurology.

In The Last Decade

Bernd Ibach

44 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernd Ibach Germany 18 300 282 187 168 164 46 861
Valentina Mantua Italy 9 318 1.1× 230 0.8× 180 1.0× 169 1.0× 48 0.3× 14 925
Gustavo Alva United States 15 204 0.7× 346 1.2× 191 1.0× 233 1.4× 82 0.5× 37 957
Giuseppe Gambina Italy 22 483 1.6× 342 1.2× 172 0.9× 259 1.5× 58 0.4× 50 1.3k
Hans‐Juergen Moeller Germany 10 261 0.9× 388 1.4× 91 0.5× 240 1.4× 49 0.3× 13 844
Minoru Yasuda Japan 20 599 2.0× 325 1.2× 123 0.7× 192 1.1× 165 1.0× 54 1.2k
S. Gracon United States 7 390 1.3× 438 1.6× 157 0.8× 395 2.4× 42 0.3× 12 1.0k
Toni M. Hoover United States 7 384 1.3× 452 1.6× 186 1.0× 384 2.3× 40 0.2× 9 1.0k
Eric Triau Belgium 5 465 1.6× 386 1.4× 174 0.9× 69 0.4× 48 0.3× 10 738
Suzuka Ataka Japan 15 647 2.2× 263 0.9× 80 0.4× 146 0.9× 105 0.6× 37 1.2k
Yvonne Wirth Germany 8 234 0.8× 321 1.1× 75 0.4× 278 1.7× 54 0.3× 12 716

Countries citing papers authored by Bernd Ibach

Since Specialization
Citations

This map shows the geographic impact of Bernd Ibach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Ibach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Ibach more than expected).

Fields of papers citing papers by Bernd Ibach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Ibach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Ibach. The network helps show where Bernd Ibach may publish in the future.

Co-authorship network of co-authors of Bernd Ibach

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Ibach. A scholar is included among the top collaborators of Bernd Ibach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Ibach. Bernd Ibach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibach, Bernd. (2019). Abhängigkeitserkrankungen des alternden und alten Menschen. 2 indexed citations
2.
Flaisch, Tobias, et al.. (2015). Implicit and Explicit Attention to Pictures and Words: An fMRI-Study of Concurrent Emotional Stimulus Processing. Frontiers in Psychology. 6. 1861–1861. 27 indexed citations
3.
Lange, Lars, Thorsten Simon, Bernd Ibach, & E. Rietschel. (2009). Shwachman-Diamond-Syndrom als Ursache eines Säuglingsekzems mit begleitender Dystrophie. Klinische Pädiatrie. 221(2). 89–92. 5 indexed citations
4.
Riepe, Matthias W. & Bernd Ibach. (2008). Neurological and Psychiatric Practitioners’ Views on Alzheimer’s Disease and Treatment Thereof. Dementia and Geriatric Cognitive Disorders. 26(6). 541–546. 11 indexed citations
5.
Plentz, Annelie, Wolfgang Jilg, Bernd Kochanowski, Bernd Ibach, & Antje Knöll. (2008). Detection of Herpesvirus DNA in Cerebrospinal Fluid and Correlation with Clinical Symptoms. Infection. 36(2). 158–162. 23 indexed citations
6.
Schumacher, Axel, Patricia F. Friedrich, Janine Diehl, et al.. (2007). No association of common VCP variants with sporadic frontotemporal dementia. Neurobiology of Aging. 30(2). 333–335. 3 indexed citations
7.
Laws, Simon M., Patricia F. Friedrich, Janine Diehl‐Schmid, et al.. (2007). Genetic analysis of MAPT haplotype diversity in frontotemporal dementia. Neurobiology of Aging. 29(8). 1276–1278. 10 indexed citations
8.
Laws, Simon M., Robert Perneczky, Alexander Drzezga, et al.. (2007). Association of the Tau Haplotype H2 With Age at Onset and Functional Alterations of Glucose Utilization in Frontotemporal Dementia. American Journal of Psychiatry. 164(10). 1577–1584. 24 indexed citations
9.
Riepe, Matthias W., et al.. (2007). Domain-Specific Improvement of Cognition on Memantine in Patients with Alzheimer’s Disease Treated with Rivastigmine. Dementia and Geriatric Cognitive Disorders. 23(5). 301–306. 24 indexed citations
10.
Schumacher, Axel, Patricia F. Friedrich, Janine Diehl‐Schmid, et al.. (2006). No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia. Neurobiology of Aging. 28(11). 1789–1790. 17 indexed citations
11.
Ibach, Bernd, Ekkehard Haen, Jörg Marienhagen, & Göran Hajak. (2005). Clioquinol Treatment in Familiar Early Onset of Alzheimer’s Disease. Pharmacopsychiatry. 38(4). 178–179. 32 indexed citations
12.
Ibach, Bernd, et al.. (2005). Effect of donepezil in patients with Alzheimer's disease previously untreated or treated with memantine or nootropic agents in Germany: an observational study. Current Medical Research and Opinion. 21(5). 723–732. 8 indexed citations
13.
Ibach, Bernd, Harald Binder, Ekkehard Haen, et al.. (2005). Cerebrospinal fluid tau and β-amyloid in Alzheimer patients, disease controls and an age-matched random sample. Neurobiology of Aging. 27(9). 1202–1211. 54 indexed citations
14.
Ibach, Bernd & Ekkehard Haen. (2004). Acetylcholinesterase Inhibition in Alzheimers Disease. Current Pharmaceutical Design. 10(3). 231–251. 155 indexed citations
15.
Ibach, Bernd, et al.. (2004). Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease. NeuroImage. 23(2). 739–743. 41 indexed citations
16.
Hensel, Anke, Bernd Ibach, Ulrich Müller, et al.. (2004). Does the Pattern of Atrophy of the Corpus callosum Differ between Patients with Frontotemporal Dementia and Patients with Alzheimer’s Disease?. Dementia and Geriatric Cognitive Disorders. 18(1). 44–49. 9 indexed citations
17.
Ibach, Bernd, Horst J. Koch, Manfred Köller, & Manfred Wolfersdorf. (2003). Hospital Admission Circumstances and Prevalence of Frontotemporal Lobar Degeneration: A Multicenter Psychiatric State Hospital Study in Germany. Dementia and Geriatric Cognitive Disorders. 16(4). 253–264. 20 indexed citations
18.
Koch, Horst J., et al.. (2003). Bestimmung der Reliabilität psychometrischer Testverfahren in der Psychiatrie mittels der kanonischen Korrelation. PubMed. 30(Suppl 2). 157–160. 3 indexed citations
19.
Ibach, Bernd, Kurt Appel, Peter J. Gebicke‐Haerter, et al.. (1998). Effect of phenytoin on cytochrome P450 2B mRNA expression in primary rat astrocyte cultures. Journal of Neuroscience Research. 54(3). 402–411. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Mantua Breakdown of academic impact, for papers by Gustavo Alva Breakdown of academic impact, for papers by Giuseppe Gambina Breakdown of academic impact, for papers by Hans‐Juergen Moeller Breakdown of academic impact, for papers by Minoru Yasuda Breakdown of academic impact, for papers by S. Gracon Breakdown of academic impact, for papers by Toni M. Hoover Breakdown of academic impact, for papers by Eric Triau Breakdown of academic impact, for papers by Suzuka Ataka Breakdown of academic impact, for papers by Yvonne Wirth
Rankless by CCL
2026